SLC39A8 and Cerebellar atrophy: Two case series from 2015 identified individuals with severe mutations in SLC39A8 presenting with a constellation of severe symptoms including intellectual disability, developmental delay, cerebellar atrophy, growth abnormalities, and seizures26,27.